Literature DB >> 30306008

In vitro antibacterial and early stage biofilm inhibitory potential of an edible chitosan and its phenolic conjugates against Pseudomonas aeruginosa and Listeria monocytogenes.

Gabjin Kim1, Chakradhar Dasagrandhi2, Eun-Hye Kang1, Sung-Hwan Eom3, Young-Mog Kim1,2.   

Abstract

In the present study, the antibacterial potential of chitosan grafted with phenolics (CPCs) such as caffeic acid (CCA), ferulic (CFA), and sinapic acid (CSA) were evaluated against foodborne pathogens like Pseudomonas aeruginosa (PA) and Listeria monocytogenes (LM). The geometric means of minimum inhibitory concentration (MIC range 0.05-0.33 mg/ml), bactericidal concentration (MBC range 0.30-0.45 mg/ml), biofilm inhibitory concentration (BIC range 0.42-0.83 mg/ml), and biofilm eradication concentration (BEC range 1.71-3.70 mg/ml) of CPCs were found to be lower than the MIC (0.12-1.08 mg/ml), MBC (0.17-1.84 mg/ml), BIC (4.0-4.50 mg/ml), and BEC (17.4-23.0 mg/ml) of unmodified chitosan against PA and LM. CPCs attenuated the biofilms of PA and LM by increasing the membrane permeability of bacteria embedded within the biofilms. Further, sub MIC of CPCs (0.5 × MIC) significantly reduced the biofilm adhesion (p < 0.001) by representative strains of LM (CCA: 72.2 ± 3.5, CFA: 79.3 ± 0.9, and CSA: 74.9 ± 1.5%) and PA (CCA: 64 ± 1.1, CFA: 67.8 ± 0.8, and CSA: 65.7 ± 4.9%). These results suggested the antibacterial and anti-biofilm potential of CPCs that can be exploited to control foodborne pathogenic infections.

Entities:  

Keywords:  Antibiofilm activity; Biofilm-forming bacteria; Chitosan-phenolic conjugates; Foodborne pathogenic bacteria

Year:  2018        PMID: 30306008      PMCID: PMC6172176          DOI: 10.1007/s13205-018-1451-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  34 in total

Review 1.  Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response.

Authors:  Morten Rybtke; Louise Dahl Hultqvist; Michael Givskov; Tim Tolker-Nielsen
Journal:  J Mol Biol       Date:  2015-08-28       Impact factor: 5.469

Review 2.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Synthesis of chitosan-alginate microspheres with high antimicrobial and antibiofilm activity against multi-drug resistant microbial pathogens.

Authors:  Rajagopalan Thaya; Baskaralingam Vaseeharan; Jeyachandran Sivakamavalli; Arokiadhas Iswarya; Marimuthu Govindarajan; Naiyf S Alharbi; Shine Kadaikunnan; Mohammed N Al-Anbr; Jamal M Khaled; Giovanni Benelli
Journal:  Microb Pathog       Date:  2017-11-11       Impact factor: 3.738

Review 4.  Synthesis, characterization, bioactivity and potential application of phenolic acid grafted chitosan: A review.

Authors:  Jun Liu; Huimin Pu; Shuang Liu; Juan Kan; Changhai Jin
Journal:  Carbohydr Polym       Date:  2017-07-12       Impact factor: 9.381

5.  Transforming data.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1996-03-23

6.  Enzymatic modification of chitosan by cinnamic acids: Antibacterial activity against Ralstonia solanacearum.

Authors:  Caifeng Yang; Yu Zhou; Yu Zheng; Changlong Li; Sheng Sheng; Jun Wang; Fuan Wu
Journal:  Int J Biol Macromol       Date:  2016-03-15       Impact factor: 6.953

7.  Efficacy of ferulic acid encapsulated chitosan nanoparticles against Candida albicans biofilm.

Authors:  Richa Panwar; Suma C Pemmaraju; Asvene K Sharma; Vikas Pruthi
Journal:  Microb Pathog       Date:  2016-02-27       Impact factor: 3.738

8.  Chitosan-hydroxycinnamic acid conjugates: preparation, antioxidant and antimicrobial activity.

Authors:  Dae-Sung Lee; Ji-Young Woo; Chang-Bum Ahn; Jae-Young Je
Journal:  Food Chem       Date:  2013-10-12       Impact factor: 7.514

9.  Correction: Chitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilms.

Authors:  Teik Hwa Ong; Ebenezer Chitra; Srinivasan Ramamurthy; Rajinikanth Paruvathanahalli Siddalingam; Kah Hay Yuen; Stephen Periathamby Ambu; Fabian Davamani
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 10.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

View more
  3 in total

1.  Addition time plays a major role in the inhibitory effect of chitosan on the production of Pseudomonas aeruginosa virulence factors.

Authors:  P Kašparová; S Boková; M Rollová; M Paldrychová; E Vaňková; K Lokočová; J Michailidu; O Maťátková; J Masák
Journal:  Braz J Microbiol       Date:  2022-03-02       Impact factor: 2.214

Review 2.  Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections.

Authors:  Dazhong Yan; Yanzhen Li; Yinling Liu; Na Li; Xue Zhang; Chen Yan
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

3.  Non-thermal plasma causes Pseudomonas aeruginosa biofilm release to planktonic form and inhibits production of Las-B elastase, protease and pyocyanin.

Authors:  Petra Kašparová; Eva Vaňková; Martina Paldrychová; Alžběta Svobodová; Romana Hadravová; Irena Jarošová Kolouchová; Jan Masák; Vladimir Scholtz
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.